The American Urological Association (AUA) announced today amendments to its clinical guideline on the Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Hyperplasia, originally published in 2018.
LINTHICUM, Md., May 2, 2019 /PRNewswire/ -- The American Urological Association (AUA) announced today amendments to its clinical guideline on the Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Hyperplasia, originally published in 2018. The amendment updates contain statements reflecting research published through January 2019, including new clinical guidance on aquablation surgical therapy. The Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline was amended as follows:
The following statement was added to the Surgical Therapy section of the Guideline:
The full text of the amended clinical guideline on Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia is available online. Members of the BPH Guideline Panel: Harris E. Foster, MD; Tobias S. Kohler, MD; Lori B. Lerner, MD; J. Kellogg Parsons, MD; Kevin T. McVary, MD. All AUA clinical practice guidance documents, including guidelines, best practices and white papers, are available online at www.auanet.org/guidelines. About the American Urological Association: Founded in 1902 and headquartered near Baltimore, Maryland, the American Urological Association is a leading advocate for the specialty of urology, and has more than 22,000 members throughout the world. The AUA is a premier urologic association, providing invaluable support to the urologic community as it pursues its mission of fostering the highest standards of urologic care through education, research and the formulation of health policy. Contact: Christine Frey, AUA
SOURCE American Urological Association |